Applied Genetic Technologies Corp (AGTC)

Stock chart
Ticker: AGTC Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Potter Stephen W
Chief Business Officer
1 sale — total 6,250 USD
Sale 1 Jul 2022
Value US$3,931,521.35 | Price 259.96 | Shares 12,937
Sale 27 May 2022
Value US$1,671,450.69 | Price 289.13 | Shares 56,282
Sale 18 Feb 2022
Value US$21,691.00 | Price 2.18 | Shares 9,950
Sale 26 Dec 2019
Value US$425,288.88 | Price 5.24 | Shares 81,162
Buy 19 Nov 2019
Value US$7,097.76 | Price 2.79 | Shares 2,544
Sale 14 Dec 2018
Value US$10,052.70 | Price 3.35 | Shares 3,000
Buy 14 Dec 2018
Value US$7,949.20 | Price 3.34 | Shares 2,380
Buy 14 Dec 2018
Value US$3,381.00 | Price 3.38 | Shares 1,000
Buy 14 Dec 2018
Value US$9,990.00 | Price 3.33 | Shares 3,000
Buy 14 Dec 2018
Value US$1,620.00 | Price 3.24 | Shares 500
Buy 14 Dec 2018
Value US$13,975.00 | Price 3.25 | Shares 4,300
Buy 14 Dec 2018
Value US$3,882.00 | Price 3.24 | Shares 1,200
Buy 16 Nov 2016
Value US$28,875.00 | Price 9.63 | Shares 3,000
Planned sale 1 Nov 2016
Value US$7,051.50 | Price 7.05 | Shares 1,000
Buy 22 Sep 2016
Value US$11,531.00 | Price 8.87 | Shares 1,300
Buy 22 Sep 2016
Value US$15,070.50 | Price 8.87 | Shares 1,700
Buy 20 Sep 2016
Value US$3,476.00 | Price 8.69 | Shares 400
Buy 19 Sep 2016
Value US$87,500.00 | Price 8.75 | Shares 10,000
Buy 16 Sep 2016
Value US$8,970.00 | Price 8.97 | Shares 1,000
Sale 23 Feb 2015
Value US$11,069,601.89 | Price 22.00 | Shares 503,150
Sale 23 Jan 2015
Value US$49,700.40 | Price 24.90 | Shares 1,996
Sale 22 Dec 2014
Value US$187,470.00 | Price 20.83 | Shares 9,000
Sale 18 Dec 2014
Value US$252,135.60 | Price 21.01 | Shares 12,000
Sale 17 Dec 2014
Value US$168,000.00 | Price 21.00 | Shares 8,000
Sale 12 Dec 2014
Value US$159,294.00 | Price 21.24 | Shares 7,500
Sale 11 Dec 2014
Value US$266,035.00 | Price 21.28 | Shares 12,500
Sale 10 Dec 2014
Value US$211,760.00 | Price 21.18 | Shares 10,000
Buy 1 Apr 2014
Value US$1,245,144.00 | Price 12.00 | Shares 103,762
Buy 1 Apr 2014
Value US$754,452.00 | Price 12.00 | Shares 62,871
Buy 1 Apr 2014
Value US$908,820.00 | Price 12.00 | Shares 75,735
Buy 1 Apr 2014
Value US$904,512.00 | Price 12.00 | Shares 75,376
Buy 1 Apr 2014
Value US$1,867,740.00 | Price 12.00 | Shares 155,645
Buy 1 Apr 2014
Value US$908,820.00 | Price 12.00 | Shares 75,735
Buy 1 Apr 2014
Value US$1,245,144.00 | Price 12.00 | Shares 103,762
Buy 1 Apr 2014
Value US$908,832.00 | Price 12.00 | Shares 75,736
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2022-07-01 2022-07-01 S Sale

Chief Business Officer

Officer
12,937 -23.5%
259.96
US$3,931,521
12,937 -23.5% 259.96 US$3,931,521
2022-05-31 2022-05-27 S Sale

Chief Accounting Officer

Officer
56,282 +21.9%
289.13
US$1,671,451
56,282 +21.9% 289.13 US$1,671,451
2022-02-22 2022-02-18 S Sale

President and CEO

Executive Director
40,214 +43.4%
340.93
US$4,488,023
40,214 +43.4% 340.93 US$4,488,023
2019-12-30 2019-12-26 S Sale Krol Patrick Johan Hendrik Large shareholder
81,162 -4.4%
5.24
US$425,289
81,162 -4.4% 5.24 US$425,289
2019-11-26 2019-11-19 B Purchase Krol Patrick Johan Hendrik Large shareholder
2,544 +0.1%
2.79
US$7,098
2,544 +0.1% 2.79 US$7,098
2018-12-18 2018-12-14 S Sale Shearman Mark S

Chief Scientific Officer

Officer
3,000 -100.0%
3.35
US$10,053
3,000 -100.0% 3.35 US$10,053
2018-12-18 2018-12-14 B Purchase Washer Susan B.

President and CEO

Executive Director
2,380 +11.7%
3.34
US$7,949
2,380 +11.7% 3.34 US$7,949
2018-12-18 2018-12-14 B Purchase Rosen James Non-Executive Director
1,000 +inf%
3.38
US$3,381
1,000 +inf% 3.38 US$3,381
2018-12-18 2018-12-14 B Purchase Sullivan William A.

Chief Financial Officer

Officer
3,000 +inf%
3.33
US$9,990
3,000 +inf% 3.33 US$9,990
2018-12-18 2018-12-14 B Purchase Aliski William Non-Executive Director
500 +6.2%
3.24
US$1,620
500 +6.2% 3.24 US$1,620
2018-12-18 2018-12-14 B Purchase Aliski William Non-Executive Director
4,300 +116.2%
3.25
US$13,975
4,300 +116.2% 3.25 US$13,975
2018-12-18 2018-12-14 B Purchase Aliski William Non-Executive Director
1,200 +48.0%
3.24
US$3,882
1,200 +48.0% 3.24 US$3,882
2016-11-17 2016-11-16 B Purchase Magovcevic Ivana Non-Executive Director
3,000 +inf%
9.63
US$28,875
3,000 +inf% 9.63 US$28,875
2016-11-02 2016-11-01 PlS Planned sale Chulay Jeffrey D.

VP and Chief Medical Officer

Officer
1,000 -4.7%
7.05
US$7,052
1,000 -4.7% 7.05 US$7,052
2016-09-26 2016-09-22 B Purchase Shearman Mark S

Chief Scientific Officer

Officer
1,300 +76.5%
8.87
US$11,531
1,300 +76.5% 8.87 US$11,531
2016-09-26 2016-09-22 B Purchase Shearman Mark S

Chief Scientific Officer

Officer
1,700 +inf%
8.87
US$15,070
1,700 +inf% 8.87 US$15,070
2016-09-27 2016-09-20 B Purchase Potter Stephen W

See Remarks

Officer
400 +40.0%
8.69
US$3,476
400 +40.0% 8.69 US$3,476
2016-09-20 2016-09-19 B Purchase BULLOCK LAWRENCE E

Chief Financial Officer

Officer
10,000 +inf%
8.75
US$87,500
10,000 +inf% 8.75 US$87,500
2016-09-27 2016-09-16 B Purchase Potter Stephen W

See Remarks

Officer
1,000 +inf%
8.97
US$8,970
1,000 +inf% 8.97 US$8,970
2015-02-24 2015-02-23 S Sale GLAXOSMITHKLINE PLC
503,150 -25.9%
22.00
US$11,069,602
503,150 -25.9% 22.00 US$11,069,602
2015-01-26 2015-01-23 S Sale Menichella Daniel L

V.P. & Chief Business Officer

Officer
1,996 -100.0%
24.90
US$49,700
1,996 -100.0% 24.90 US$49,700
2014-12-23 2014-12-22 S Sale Menichella Daniel L

V.P. & Chief Business Officer

Officer
9,000 -100.0%
20.83
US$187,470
9,000 -100.0% 20.83 US$187,470
2015-02-12 2014-12-18 S Sale GLAXOSMITHKLINE PLC Large shareholder
12,000 -0.6%
21.01
US$252,136
12,000 -0.6% 21.01 US$252,136
2015-02-12 2014-12-17 S Sale GLAXOSMITHKLINE PLC Large shareholder
8,000 -0.4%
21.00
US$168,000
8,000 -0.4% 21.00 US$168,000
2015-02-12 2014-12-12 S Sale GLAXOSMITHKLINE PLC Large shareholder
7,500 -0.4%
21.24
US$159,294
7,500 -0.4% 21.24 US$159,294
2015-02-12 2014-12-11 S Sale GLAXOSMITHKLINE PLC Large shareholder
12,500 -0.6%
21.28
US$266,035
12,500 -0.6% 21.28 US$266,035
2015-02-12 2014-12-10 S Sale GLAXOSMITHKLINE PLC Large shareholder
10,000 -0.5%
21.18
US$211,760
10,000 -0.5% 21.18 US$211,760
2014-04-02 2014-04-01 B Purchase GLAXOSMITHKLINE PLC Large shareholder
103,762 +5.5%
12.00
US$1,245,144
103,762 +5.5% 12.00 US$1,245,144
2014-04-01 2014-04-01 B Purchase Rosen James Non-Executive Director Large shareholder
62,871 +5.5%
12.00
US$754,452
62,871 +5.5% 12.00 US$754,452
2014-04-01 2014-04-01 B Purchase MedImmune Ventures, Inc. Large shareholder
75,735 +5.5%
12.00
US$908,820
75,735 +5.5% 12.00 US$908,820
2014-04-01 2014-04-01 B Purchase INTERWEST PARTNERS VIII LP Large shareholder
75,376 +5.5%
12.00
US$904,512
75,376 +5.5% 12.00 US$904,512
2014-04-01 2014-04-01 B Purchase Alta Partners VIII, L.P. Large shareholder
155,645 +5.5%
12.00
US$1,867,740
155,645 +5.5% 12.00 US$1,867,740
2014-04-01 2014-04-01 B Purchase Wu Samuel Non-Executive Director Large shareholder
75,735 +5.5%
12.00
US$908,820
75,735 +5.5% 12.00 US$908,820
2014-04-01 2014-04-01 B Purchase Carroll Jill Non-Executive Director Large shareholder
103,762 +5.5%
12.00
US$1,245,144
103,762 +5.5% 12.00 US$1,245,144
2014-04-01 2014-04-01 B Purchase ORONSKY ARNOLD L Non-Executive Director Large shareholder
75,736 +5.5%
12.00
US$908,832
75,736 +5.5% 12.00 US$908,832